Polymyalgia Rheumatica Treatment Market would grow upto USD 513.47 million by 2029

The global polymyalgia rheumatica treatment market is expected to witness significant growth during the forecast period. This disorder mainly occurs in ageing people aged above 60 years. It is more dominant in females than males, with a ratio of 2:1. Polymyalgia rheumatica is an autoimmune disease with no identified cause, however its been suggested that there is a link between genetic and environmental factors leading to the spread of this condition. Sudden outbreak of the COVID-19 pandemic imposed stringent lockdown regulations globally, causing interruptions in import and export activities of global mucormycosis market.

View Detailed Report: https://www.databridgemarketresearch.com/reports/global-polymyalgia-rheumatica-treatment-market

Data Bridge Market Research analyses a growth rate in the global polymyalgia rheumatica treatment market in the forecast period 2022-2029. The expected CAGR of global polymyalgia rheumatica treatment market is tend to be around 14% in the mentioned forecast period. The market was valued at USD 180 million in 2021, and it would grow upto USD 513.47 million by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Key players operating in the global polymyalgia rheumatica treatment market include:

F. Hoffmann-La Roche Ltd. (Switzerland)

Mylan N.V. (U.S.)

Teva Pharmaceutical Industries Ltd. (Israel)

Sanofi (France)

Pfizer Inc. (U.S.)

GSK plc (U.K.)

Novartis AG (Switzerland)

AstraZeneca (U.K.)

Johnson & Johnson Private Limited (U.S.)

Sun Pharmaceutical Industries Ltd. (India)

Merck & Co., Inc. (U.S.)

Lilly (U.S.)

Amgen Inc. (U.S.)

PuraCap® Pharmaceutical LLC (U.S.)

Glenmark Pharmaceuticals Limited (India)

Market Definition

Polymyalgia rheumatica is a type of inflammatory disorder which causes inflammation, stiffness and muscle pain around the shoulders, neck and hips. It is prompted by numerous factors such as genetic and environmental factors. Polymyalgia rheumatica is often related with giant cell arteritis (GCA). This situation results in increased swelling of arteries in head, which can lead to blurred vision and headaches. This disease prevalence is rising and important diagnostic procedures and treatments will boost the growth of the market.

Opportunities

Increased Advanced Diagnostic Technology

Growing research on polymyalgia rheumatica to understand and study its association with musculoskeletal symptoms is expected to expand the market growth. The introduction of several advanced diagnostic technologies to analyse several conditions boost the industry growth. Furthermore, technological advancements in imaging tests such as magnetic resonance imaging (MRI) are reducing its scorer bias to diagnose the disease efficiently. MRI can detect asymptomatic cases of polymyalgia rheumatica, hence it is increasing the demand for its treatment. All these factors are also contributing in the growth of the market.  

Global Polymyalgia Rheumatica Treatment Market Scope

The global polymyalgia rheumatica treatment market is segmented on the basis of drug class, fungi type, route of administration,end-user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Class

Corticosteroids

Disease-Modifying Anti-Rheumatic Drugs (DMARDS)

Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)

Others 

Route of Administration

Oral

Parenteral

Others

End-Users

Hospitals

Homecare

Specialty Clinics

Others

Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Online Pharmacies

Others

Explore More Reports:

https://databridgemarketresearchreports.blogspot.com/2024/03/content-moderation-solution-market.html

https://databridgemarketresearchreports.blogspot.com/2024/03/dental-intraoral-scanners-market.html

https://databridgemarketresearchreports.blogspot.com/2024/03/bacteriophages-therapy-market-to-reach.html

https://databridgemarketresearchreports.blogspot.com/2024/03/ready-to-drink-rtd-beverages-market-to.html

About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact Us:
Data Bridge Market Research
Tel: +1-888-389.80-2818 | +44 208 089 1725 | +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com

This release was published on openPR.